Zai Lab

Zai Lab is a China-based biotechnology firm that develops transformative medicines for the treatment of cancer, autoimmune and infectious diseases.

Business Model:

Revenue: $65.3M

Employees: 1,001-5,000

Detailed Zai Lab Information

Geographic Data

Zai Lab headquarters map

Address: 4560 Jinke Road

City: Pudong

State: shanghai municipality

Zip: 201210

Country: CN

Financial Info

Stage:

post ipo equity

Raised Last:

$858M

Raised Total:

$1B

Metrics

586,380Website Global Rank

75,641Website Monthly Traffic

Twitter Followers

Description

Zai Lab is a China-based biotechnology firm that develops transformative medicines for the treatment of cancer, autoimmune and infectious diseases.

Contact Phone:

Contact Email:

Zai Lab went public on 9/20/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/20/2017

IPO Valuation:
$1B

Ticker Symbol:
ZLAB

IPO Price:
$27.9/share

Amount Raised:
$158M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
12/2016 dMed Series A 8M
12/2016 dMed Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2018 Secondary Offering $150M
9/2017 IPO $150M
4/2021 Private Placement $750M
1/2016 Series B $100M OrbiMed
Qiming Ventures
Sequoia Capital China
5/2019 Post-IPO Equity $215.4M
1/2020 Post-IPO Equity $280.6M
4/2015 Series A 3 $18.3M Sequoia Capital China
Qiming Venture Partners
Kleiner Perkins
8/2014 Series A 4 $10M Qiming Venture Partners
TF Capital
Sequoia Capital China
Kleiner Perkins
Qiming Venture Partners
1/2016 Series B 5 $106.2M Sequoia Capital China
Qiming Venture Partners
OrbiMed
Advantech Capital
TF Capital
Advantech Capital
Sequoia Capital China
Qiming Venture Partners
OrbiMed
Advantech Capital
TF Capital
Advantech Capital
6/2017 Series C 5 $30M Vivo Capital
Cormorant Asset Management
OrbiMed
Rock Springs Capital
Qiming Venture Partners
OrbiMed
Vivo Capital
Cormorant Asset Management
OrbiMed
Rock Springs Capital
Qiming Venture Partners
OrbiMed
4/2021 Post-IPO Equity $857.5M
9/2018 Post-IPO Equity $140.3M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research